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Abstract
Background: Family history is a common risk factor for colorectal cancer (CRC), yet it is often underused to guide
risk assessment and the provision of risk-appropriate CRC screening recommendation. The aim of this study was to
identify from a patient perspective health care providers’ current practice relating to: (i) assessment of family history
of CRC; (ii) notification of “increased risk” to patients at “moderately/potentially high” familial risk; and (iii)
recommendation that patients undertake CRC screening.
Methods: 1592 persons aged 56-88 years randomly selected from the Hunter Community Study (HCS), New South
Wales, Australia were mailed a questionnaire. 1117 participants (70%) returned a questionnaire.
Results: Thirty eight percent of respondents reported ever being asked about their family history of CRC. Ever
discussing family history of CRC with a health care provider was significantly more likely to occur for persons with
a higher level of education, who had ever received screening advice and with a lower physical component
summary score. Fifty one percent of persons at “moderately/potentially high risk” were notified of their “increased
risk” of developing CRC. Thirty one percent of persons across each level of risk had ever received CRC screening
advice from a health care provider. Screening advice provision was significantly more likely to occur for persons
who had ever discussed their family history of CRC with a health care provider and who were at “moderately/
potentially high risk”.
Conclusions: Effective interventions that integrate both the assessment and notification of familial risk of CRC to
the wider population are needed. Systematic and cost-effective mechanisms that facilitate family history collection,
risk assessment and provision of screening advice within the primary health care setting are required.
Background
Colorectal cancer (CRC) screening: reduces the burden of
disease
Worldwide, CRC comprises 9.4% of all cancer cases with
one million diagnoses annually [1]. Survival from CRC is
highly stage-dependent yet fewer than 40% of CRCs are
diagnosed at a localised stage [2]. Screening is a cost-
effective mechanism that reduces the incidence and
mortality associated with CRC [3-5]. Population-based
screening is recommended for those aged 50 years or
older, with average-risk persons recommended to
receive periodical Faecal Occult Blood Test (FOBT)
screening or endoscopy screening, dependent on screen-
ing guidelines [6,7]. Several randomised controlled trials
(RCTs) have indicated it is possible to reduce mortality
from CRC mortality by 15% to 33% with Faecal Occult
Blood Test (FOBT) screening on either an annual or
biennial basis[3,4,8-10]. Recent RCT evidence of once-
only flexible sigmoidoscopy for persons 55-64 years of
a g ep r o v i d e ss t r o n ge v i d e n c ef o rt h es u b s t a n t i a la n d
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indicated a one-third reduction of incidence and 40%
reduction in mortality for persons undertaking sigmoi-
doscopy screening [11]. Although colonoscopy remains
untested in randomised trials, case control and cohort
studies using large-bowel endoscopy have shown a CRC
mortality reduction rate ranging from 60% to 76% [12]
and incidence reduction of 76% to 90% [5].
Family history is a common and important risk factor
Relatives of CRC patients are a group that can benefit
from targeted screening or prevention programs [13].
Approximately 15% to 20% of CRC cases occur in per-
sons who have a first degree relative with the disease
[14-16]. Relative risk is up to two-fold for persons with
a first-degree relative diagnosed with CRC and three- to
six- fold for families with additional factors such as
early onset of CRC or multiple relatives affected [6,17].
The presence of genetically-based familial syndromes,
such as hereditary non-polyposis CRC (HNPCC) and
familial adenomatous polyposis (FAP) further increases
the risk of CRC in first-degree relatives [7,14]. Screening
guidelines in Australia categorise asymptomatic indivi-
duals into three levels of risk: “at or slightly above aver-
age risk"; “moderately increased risk’;a n d“potentially
high risk”. Risk is quantified based on family history of
CRC: number and type of relative diagnosed (first or
second-degree relative) and their age at diagnosis, with
additional high-risk features considered [6].
CRC risk assessment in the primary care setting
Health care providers play an integral role in cancer
control by identifying those individuals whose behaviour,
e n v i r o n m e n to rf a m i l yh i s t o r yp l a c et h e ma ti n c r e a s e d
risk of CRC [18].
In Australia, CRC screening guidelines entrust health-
care providers with preventive practices relating to:
patient family history of CRC assessment; the notifica-
tion of persons at increased-risk; and the provision of
risk-appropriate CRC screening advice [6]. However,
evidence suggests that family-health histories are seldom
taken in primary-care [19]. This may be due to the com-
peting demands for care and time factors that are placed
on general practitioners [20,21]. In addition, the com-
plexity of familial-risk interpretation and the lack of sys-
tematic collection and assessments methods to assist
primary-care providers further compound this problem
[19]. Retrospective chart audits have demonstrated that
40% to 55% of patient medical records include impor-
tant family history information (i.e. the presence or
absence of breast or bowel cancer) [22,23]. Clinicians’
self reported rate of patient family history assessment
ranges from 30% to 90% [24,25]. Direct observation stu-
dies suggest discussion of family history may occur in
51% of visits by new patients and 22% of visits with
established patients [26]. However, relatively little is
known about current practice relating to health care
providers’ identification and notification of persons at
elevated-risk of CRC. The few studies [18,23,27,28]
which have assessed this issue have been conducted
within North American family practice settings adopting
patient record audit.
The opportunity often missed: CRC screening
recommendation to patients
Medical practitioner recommendation can increase the
likelihood of complying with CRC screening up to 23-
times [29,30], with over 75% of persons reporting that
they would undertake screening if it were recommended
by a doctor [31,32]. Nonetheless, CRC screening recom-
mendations are neither routinely nor consistently pro-
vided to at-risk patients [33-36]. Population-based data
from the United States National Health Interview Survey
(NHIS) indicated that only 10% of under-screened
patients who had visited their doctor in the previous
year had received a CRC screening recommendation
[35]. In Australia, a recent evaluation of at-risk persons
(aged 30-70 years) presenting to an out-patient hospital
setting identified that 22% of persons had ever received
any CRC screening recommendation from their medical
practitioner [37].
To our knowledge the current study presents as the
first community-based evaluation of health care provi-
ders practice relating to CRC family history assessment
and notification of “increased risk” to persons at ele-
vated levels of familial risk ("moderately increased/
potentially high risk”). Further, the socio-demographic,
lifestyle or psychosocial factors associated with family
history assessment of CRC and provision of screening
advice outside of the general practice setting is under-
studied [35]. Both the identification of these factors and
sub-groups less likely to receive CRC family history
assessment and screening advice is of importance for
the development and improvement of future preventive
programs in the general practice setting. The aim of this
study was to examine among a community-based cohort
of at-risk persons (aged 56-88 years), the proportion of
respondents:
(i) Who had ever been asked by a health care provider
about their family history of CRC
(ii) At elevated levels of familial risk ("moderately
increased/potentially high risk”) who had been notified
by a health care provider of their “increased risk” of
developing CRC.
(iii) Who had ever received CRC screening advice
from a health care provider.
Socio-demographic, clinical and psychosocial charac-
teristics associated with ever asked about family history
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identified.
Methods
Design and study population
The Hunter Community Study (HCS) sample is a longi-
tudinal cohort of community dwelling men and women
aged 55-85 years at baseline in the Hunter Region,
NSW, Australia [38]. Participants were randomly
selected from the NSW State electoral roll between
December 2004 and 2007. The HCS cohort reflects the
Hunter Region, state and national profiles for gender
and marital status, but is slightly younger in age [38]. A
randomly selected sub-sample of HCS participants (n =
1592) aged 56-88 years at time of survey (November,
2009) were mailed a pen and paper questionnaire.
Questionnaire
Respondents were asked about health care providers’
practice relating to assessment of family history of CRC
- “Has any health professional e.g. your doctor, ever
asked if you have a family history of bowel cancer” (Yes/
No), notification of “increased risk” of developing CRC -
“Did this person discuss whether there was a possible
‘increased risk’ of developing bowel cancer for you or
your family members?” (Yes/No), and the provision of
CRC screening information - “Has any health profes-
sional suggested that you or your relatives should do
any of the following: Please choose all that apply.” (i.
Start having screening tests for bowel cancer/ii. Talk to
their doctor about screening tests/iii. No advice has ever
been given/iv. Take other action related to bowel cancer
(please specify___). Responses to questions relating to
ever asked about family history of CRC by a health care
provider and notification of possible increased risk were
used to derive a Discussion of family history of CRC with
doctor variable with three levels (never discussed, dis-
cussed and informed of possible “increased risk”,d i s -
cussed and not informed of possible “increased risk”).
Respondents’ answers concerning provision of CRC
screening information were used to derive an ever
received screening advice from doctor variable (Yes/No).
Respondents indicating (i), (ii), or (iv) were coded as
("Yes”) to receiving screening advice while respondents
answering (iii) were coded as ("No”).
Respondents familial risk based on self reported family
history of CRC
Respondents were asked separately whether any first- or
second- degree relatives had ever been diagnosed with
CRC and if so, their age at diagnosis. Survey items used
to assess family history of CRC are presented in Addi-
tional file 1: Appendix A. Respondents’ self reported
family history of CRC was used to allocate persons to
their level of risk in accordance with current clinical
practice guidelines (see Table 1).
Statistical Analysis
Frequency distributions (n/%) with 95% confidence
interval were used to assess the proportion of respon-
dents that had ever been asked about their family his-
t o r yo fC R Cb yah e a l t hc a r ep r o v i d e r( Y e s / N o )a n d
ever received CRC screening advice (Yes/No). For per-
sons at elevated level of risk ("moderately increased/
potentially high risk”) the proportion notified of their
“increased risk” was identified. The following items
selected from the HCS databank were assessed as poten-
tial correlates of ever asked about family history of CRC
and ever received CRC screening advice: Socio-demo-
graphic and lifestyle, i.e. age, gender, education, marital
status, country of birth, household income, retirement,
private health insurance status, tobacco or alcohol use;
Clinical, i.e. general practice visits per year, previous
cancer diagnosis (excluding CRC), body mass index, and
co-morbidity (e.g. high cholesterol, hypertension,
asthma, diabetes); and psychosocial,i . e .p h y s i c a lh e a l t h ,
assessed using the physical health component summary
score (PCS) on the short form health survey SF-36 [39],
and mental health assessed using the Kessler Psychologi-
cal Distress Scale (K-10) [40]. The PCS is a physical
health summary score aggregated from the physical
functioning, role-physical, bodily pain and general-health
scales on the SF-36 [41]. Multiple logistic regression
analysis was used to determine independent factors
associated with ever asked about family history of CRC
by a health care provider and ever received CRC screen-
ing advice. Variables with a p value < .25 following sim-
ple logistic regression analysis (See Additional file 1:
Appendix B) were entered into multiple logistic regres-
sion model (with both forward and backward stepwise
elimination used to check consistency of results). Vari-
ables that met the significance cut-point of (p value <
.05) were entered into the final model. Data were ana-
lysed using STATA 11 (STATA, Texas, USA).
Ethics approval
The University of Newcastle and Hunter New England
Population Health Human Research Ethics Committees
granted ethical approval.
Results
Characteristics of the sample
Of the 1592 mailed surveys, 1117 respondents com-
pleted and returned surveys (response rate, 70%).
Respondents previously diagnosed with CRC (n = 24)
or reporting they had undergone major abdominal sur-
gery (n = 8) were excluded from analysis, leaving a
total sample of 1085 eligible participants with data.
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information for the purposes of risk allocation. Socio-
demographic characteristics and the proportion of
respondents at each level of risk are presented in
Table 2.
Family history of CRC assessment
1050 respondents provided information on “ever asked
about family history of CRC by a health care provider”
(Yes/No). Overall 38.3% (95% CI, 35.3 - 41.3) of respon-
dents had ever been asked if they had a family history of
CRC by a health care provider. Risk category specific
r a t e sw e r ea sf o l l o w s :“at or slightly above average risk”
(36.6%, 33.6 - 39.7), “moderately increased risk” (54.9%,
40.3 - 68.9) and “potentially high risk” (65.6%, 45.7 -
82.1). Table 3 presents the results of the multiple logis-
tic regression analysis. Persons with a higher education
(university or other tertiary study), ever receiving
screening advice from a health care provider and with
lower physical component summary (PCS) score on the
SF-36 were significantly more likely to have ever had
been asked about their family history of CRC by a
health care provider.
Health care providers’ practice relating to notification of
“increased risk” to persons at elevated levels of risk
("moderately increased/potentially high risk”)
Of the 82 respondents classified at “moderately
increased risk” or “potentially high risk”, 78 persons pro-
vided information relating to “discussion of family his-
tory of CRC with doctor”. 42.3% (95% CI 31.2 - 54.0) of
such persons had never been asked by a health care pro-
vider about their family history of CRC. 51.3% (39.7 -
62.8) had been both asked about their family history of
CRC and notified of possible “increased risk”.Af u r t h e r
6.4% (2.1-14.3) had been asked about their family history
of CRC but were not informed of any possible
“increased risk”.
Health care providers’ practice relating to CRC screening
recommendation
Across the entire cohort 978 respondents provided
information on CRC screening advice. Overall, 31.1%
(95% CI 28.2 - 34.1) of respondents had ever received
screening advice from a health care provider. Risk-speci-
fic rates of receiving screening advice for persons were:
Table 1 Criteria used to define risk categories in accordance with national CRC screening guidelines.
Risk Category*
At or slightly above
average risk
￿ No personal history of bowel cancer. ￿ Either no close relatives with bowel cancer or one first-degree or second-degree
relative with bowel cancer diagnosed at age 55 years or older.
Moderately increased risk ￿ One first-degree relative diagnosed before the age of 55 years (without potentially high-risk features listed below), or ￿
Two first-degree relatives or one first- and one second-degree relative(s) on the same side of the family (without
potentially high-risk features listed below).
Potentially high risk ￿ Three or more first-degree or a combination of first-degree and second-degree relatives on the same side of the family
diagnosed with bowel cancer (suspected HNPCC**), or Two or more first-degree or second-degree relatives on the same
side of the family diagnosed with bowel cancer, including the following risk feature: bowel cancer before the age of 50
years or at least one-relative with cancer of the endometrium, ovary, stomach, small bowel, renal pelvis, ureter, biliary
tract or brain.
* Risk features potentially placing persons at possible increased risk, including personal history of adenoma, inflammatory bowel disease or suspected familial
adenomatous polyposis (FAP) were not assessed in the survey. **HNPCC (Hereditary non-polyposis colorectal cancer), also known as Lynch syndrome.
Table 2 Socio-demographic characteristics of study
respondents (n = 1085)
Characteristic n %
Gender
Male 508 47
Female 577 53
Age (years)
56-64 455 42
65-74 382 36
75-88 237 22
Country of Birth
Australia 885 89
Other 111 11
Marital status
In a relationship 805 77
Not in relationship 240 23
Risk category
At or slightly above average risk 979 92
Moderately increased risk 52 5
Potentially high risk 30 3
Annual household income before tax ($)
< = 39, 999 574 58
40, 000 - 69, 999 216 22
> = 70,000 197 20
Highest Level of Education
Secondary schooling (not-completed) 229 22
Secondary schooling (completed) 241 23
Trade qualification or TAFE: 264 25
University or other tertiary study 256 25
Other or not applicable 53 5
* Percentage of responses (excluding any missing values).
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age risk”, 67.3% (24.8-30.7) for those at “moderately
increased risk” and 80.8% (60.6-93.4) for those at
“potentially high risk”. Multiple logistic regression analy-
sis (See Table 4) found that persons: at elevated level of
risk ("moderately increased/potentially high risk”)a n d
who had ever discussed family history of CRC with doc-
tor irrespective of whether informed of “increased risk”
were significantly more likely to ever had received
screening advice from a health care provider.
Risk notification and CRC screening recommendation for
persons at elevated levels of risk ("moderately increased/
potentially high risk”)
Of the 82 respondents at either ‘moderately increased
risk’ or ‘potentially high risk’ 72 persons provided infor-
mation on both ‘discussion of family history of CRC with
doctor’ and ‘ever received CRC screening advice’.F o r
respondents at each respective level of risk; 95% (38/40)
of persons notified of their ‘increased risk’ of CRC had
ever received screening advice compared to 37% (10/27)
of respondents who had never discussed their family his-
tory of CRC with a doctor. Eighty per cent (4/5) of per-
sons who had discussed their family history of CRC with
a doctor but were not informed of their ‘increased risk’
had ever received CRC screening advice.
Discussion
Study findings indicate that opportunities for earlier
detection of CRC are being missed, with 38% of all
respondents ever asked about their family history of
CRC by a health care provider. Of concern is that close
to half of persons at “moderately increased/potentially
high risk” had not been notified of their “increased risk”
by a health care provider. Overall, the rate of screening
advice was low with approximately one-third of respon-
dents irrespective of risk category ever receiving CRC
screening advice from a health care provider.
Risk-based colorectal cancer screening
Before further consideration of study findings, the
importance of “risk-based” screening and some
Table 3 Multiple logistic regression analysis (n = 870)* of factors associated with ever asked about family history of
CRC by a health care provider
Asked by health care provider n (%) OR (95%CI) p- value
Education
Secondary schooling (not-completed) 61 (34) 1
Secondary schooling (completed) 67 (33) .99 (.61, 1.62) .974
Trade qualification or TAFE: 83 (38) 1.24 (.77, 2.00) .373
University or other tertiary study 108 (48) 2.14 (1.34, 3.45) .002
Other or not applicable 19 (44) 1.89 (.88, 4.05) .102
Ever received screening advice from
doctor
Yes 206 (73) 10.11 (7.24, 14.12) .000
No 132 (22) 1
SF-36 (PCS) - .98 (.96, .99) .012
* Respondents excluded from model due to missing values (n = 191)
Table 4 Multiple logistic regression analysis (n = 956)* of factors associated with ever receiving CRC screening advice
from a health care provider
Received screening advice
n (%)
OR (95%CI)* p-value
Risk Category
At or slightly above average risk 239 (27) 1
Moderately increased risk 32 (68) 4.45 (2.07, 9.55) .000
Potentially high risk 20 (80) 6.92 (2.20, 21.71) .001
Discussion of family history of CRC with doctor
Never discussed 81 (13) 1
Discussed/informed of ‘increased’‘ risk’ 152 (76) 17.96 (11.97, 26.95) .000
Discussed/not informed of increased ‘risk’ 58 (38) 4.12 (2.73, 6.20) .000
* Respondents excluded from model due to missing values (n = 105)
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addressed. Population-level screening has demonstrated
effectiveness with RCTs indicating a CRC mortality
reduction between 15 to 33% [3,4,8-10], with a slightly
higher benefit secured from sigmoidoscopic screening
[11]. At present, there is still no RCT evidence for colo-
noscopy screening. While population-level screening
indicates efficacy for the “average risk” population it
does not cater for the tailored screening requirements of
higher risk groups. Risk-based screening, as adopted in
the Australian clinical practice guidelines [6], is an
attempt to address the critical relationship between
strong family history of CRC and the increased likeli-
hood of developing the disease. This risk-based
approach to screening, also acknowledges the problem
of over screening, which can be harmful, costly and
unnecessary. While it is pertinent all patients receive
CRC screening advice from their healthcare provider, it
is critical that family history of cancer discussions guide
risk-appropriate CRC screening provision to patients.
Correct risk assignment and clinical management is of
critical importance for patients with family histories sug-
gestive of hereditary cancer syndromes.
Family history assessment in the primary care setting
Family history assessment is important for identification
of those who may benefit from tailored screening or
referral to genetic services. This study suggests that the
important first-step in identification of risk - discussion
of family history of CRC- often does not occur. Such
findings are consistent with previous data identifying
poor documentation of family history information in the
family practice setting [18,23,26,28,42]. It must be
acknowledged that family history assessment and notifi-
cation of risk does not ensure continued adherence to
screening recommendations [43]. Nonetheless, risk com-
munication is an essential prerequisite to patients’
understanding of their risk. Current study findings sug-
gest the need for strategies that help to improve the
assessment of family history of CRC and the identifica-
tion of potential familial risk in the primary care-setting
Improving family history assessment and referral
Health care providers report the need for clear guidance
on the risk stratification and referral process of patients
[44,45]. Further refinement of user-friendly guidelines
that help to facilitate identification and referral of
increased-risk patients is an important yet necessary
step forward as suggested by other researchers
[18,42,44,46]. The cumbersome and time-consuming
nature of family history assessment has been a barrier to
accurate assessment of familial risk [46-48], which may
in part be overcome by the advent of computerised
Cancer Risk Assessment Tools (CRATs) which have
helped to standardise and simplify family history assess-
ment [49,50]. Interventions using this technology
designed to efficiently assess and automate risk stratifi-
cation are likely to increase the utility of family history
assessment in the primary health care setting [51].
Recent cluster randomised controlled trials have demon-
strated this tool’s effectiveness in the management of
familial breast and CRC including a trial which com-
pared a computer decision support aid versus best evi-
dence practice (education and guideline dissemination)
[19,52].
Improving the CRC screening message to the at-risk
population
Current findings indicate the need for practice-based
strategies that systematically prompt health care provi-
ders to encourage CRC screening among at-risk
patients, especially given patients are often reluctant to
initiate discussions [53]. Little data exists on how often
CRC screening is included in office reminder systems
and the reasons for under utilisation in the primary
health care setting [53]. Although meta-analyses have
demonstrated that minimal prompts to patients and
providers are effective in enhancing CRC screening with
FOBT[54], research suggests very limited use of such
reminder systems for CRC screening [54,55]. Intuitively
maximising the wider adoption of simple systematic
practice-based interventions that include prompts to
health care providers for CRC screening may assist in
elevating CRC screening rates across the at-risk
population.
Study limitations
The findings should be interpreted in light of some meth-
odological limitations. Health care providers’ practices
relating to preventive measures in this study were based
on self-report with associated potential for recall bias. Self-
reported family history of CRC was not validated against
objective sources, a limitation however that is consistent
with other published studies that have used patient record
audit [18,23,28]. For a small minority of respondents at
“moderately increased/potentially high risk”,t h el e v e lo f
risk may have been overestimated. For respondents indi-
cating that both a first- and second-degree relative were
diagnosed with CRC, an assumption was made that both
relatives were diagnosed on the same side of the family.
Participants’ report of health care providers’ assessment of
patient family history of CRC may have been underesti-
mated due to several factors including recall bias. It is pos-
sible that health care providers may have asked a broader
question about family history of cancer or respondents
could have instigated family history discussions without
health care providers’ initiation. However, the literature
suggests such patient initiation is rare[53]. Alternatively,
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familial risk from information obtained previously from
other relatives in the family with notification of “increased
risk” given on this basis. Further, it is important to con-
sider that for some persons their risk-status may have
changed over-time (since first discussion of family history
with a doctor). That is, some persons asked about their
family history of CRC (years prior to survey completion)
may have had no family history of CRC at this time and
were correctly notified of no “increased risk”, yet at a later
stage, following a relative’s diagnosis of CRC were notified
by a doctor of their “increased risk”. While this may have
occurred in a small number of persons, the literature sug-
gests that periodic updating of family history of CRC
information is seldom conducted in the primary-care set-
ting [22,26,56]. Subsequently, it is highly possible that for
the most part, persons with a changed family history of
CRC overtime would not have been notified of their chan-
ged risk status. Finally, some participants (recently turning
55 or 65 years of age) may have had recent contact with
the National Bowel Cancer Screening Program prior to
survey completion. As part of this program, an FOBT
screening invitation and information on familial risk and
CRC screening is provided, which may have increased
CRC awareness in this particular respondent group.
Conclusions
The current study’s evaluation of patient self-report sug-
gests that family history of CRC discussions with a
health care provider had occurred in a minority of
cases. Consequently, many families at the greatest risk
of developing CRC may have missed a vital opportunity
to gain benefits from increased risk notification, risk-
appropriate screening and adequate referral to genetic
consultation. Greater emphasis on the refinement and
development of user-friendly referral guidelines, the
wider incorporation of office-based reminder and com-
puter-based technology to facilitate risk assessment and
CRC screening recommendation is required.
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